Assessing the Role of Family History and Polygenic Risk Scores in the Risk of Cardiometabolic Disorders - Top-Institutions - MDSpire

Assessing the Role of Family History and Polygenic Risk Scores in the Risk of Cardiometabolic Disorders

  • By

  • Ebuka Onyenobi

  • Knightess Oyibo

  • Michael Zhong

  • Sally N. Adebamowo

  • February 3, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Broad Institute of MIT and Harvard
    Broad Institute of MIT and Harvard

    Cambridge, MA

    Key Differentiators

    • Genomic Medicine
    • Cardiometabolic Research
    • Statistical Genetics

  • #2

    Massachusetts General Hospital (MGH) and Harvard Medical School
    Massachusetts General Hospital (MGH) and Harvard Medical School

    Boston, MA

    Key Differentiators

    • Cardiology
    • Endocrinology
    • Genomic Medicine

  • #3

    University of Michigan Medical School
    University of Michigan Medical School

    Ann Arbor, MI

    Key Differentiators

    • Genetic Epidemiology
    • Cardiometabolic Disease Research
    • Biostatistics

  • #4

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Genomic Medicine
    • Cardiology
    • Precision Health

  • #5

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Genetic Epidemiology
    • Public Health Genomics

Original Source(s)

Assessing the Role of Family History and Polygenic Risk Scores in the Risk of Cardiometabolic Disorders

  • by Ebuka Onyenobi, Knightess Oyibo, Michael Zhong, Sally N. Adebamowo

  • February 3, 2026

Related Content

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

Pheochromocytoma complicated with acute myocardial infarction and cerebral infarction: a case report